// App-Quantinova.ai

OC 11.1 : Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and strength; results from a sub-study of the FEISTY trial

Researchers

Presenter

  • G. Morrow

Principal Investigators

  • T. Feller

  • Z. McQuilten

  • R. Arins

  • N. Mutch

  • M. Laffan

  • N. Curry

Medical Centers

  • University of Aberdeen, Aberdeen, Scotland, United Kingdom

  • Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom

  • Deakin University, Melbourne, Australia

  • Gold coast university hospital, Gold Coast, Qld, Australia

  • Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom

  • University of Aberdeen, Aberdeen, Scotland, United Kingdom

  • Centre for Haematology, Imperial Collegel, London, United Kingdom

  • University of Oxford, Oxford, United Kingdom

Locations

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Trauma

Biomarkers

  • Plasminogen activator ihnibitor-1

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved